A study on ethosomes as mode for transdermal delivery of an antidiabetic drug

Drug Delivery

Volumn 20, Issue 1, 2013, Pages 40-46

  Bodade, Siddhodhan S ^a   Shaikh, Karimunnisa Sameer ^a   Kamble, Meghana S ^a   Chaudhari, Praveen D ^a  

^a Affiliated to Savitribai Phule Pune University   (India)

Author keywords

Diabetes; Factorial design; Repaglinide; Response surface; Vesicular

Indexed keywords

ALCOHOL; DIPALMITOYLPHOSPHATIDYLCHOLINE; DRUG CARRIER; ETHOSOME; REPAGLINIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG RELEASE; FIRST PASS EFFECT; FOURIER ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ADMINISTRATION, CUTANEOUS; ANIMALS; CARBAMATES; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HYPOGLYCEMIC AGENTS; ORGAN CULTURE TECHNIQUES; PIPERIDINES; RATS; RATS, WISTAR; SKIN ABSORPTION;

EID: 84872237892     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2012.752420     Document Type: Article

References (18)

1. Ambavane V, Patil R, Ainapure S. (2002). RPG: a short acting insulin secretagogue for postprandial hyperglycaemia. Drug Rev 48:246-8.
2. Ashoniya S, Chauhan M. (2001). Ethosomes as vesicular carrier for enhanced transdermal delivery of Ketoconazole-formulation and evaluation. J Pharm Cosmeto 3:1-14.
3. Elisabetta E, Enea M, Rita C. (2004). Ethosomes and liposomes as topical vehicles for azelaic acid: a preformulation study. J Cosmetic 55:253-64.
4. Elsayed M, Abdallah OY, Naggar VF, Khalafallah NM. (2007). Lipid vesicles for skin delivery of drugs: reviewing three decades of research. Int J Pharm 332:1-16.
5. Godin B, Touitou E. (2005). A new approach for treatment of deep skin infections by an ethosomal antibiotic preparation: an in vivo study. J Antmicrob Chemo 55:989-94.
6. Jadhav SM, Morey P, Karpe M, Kadam V. (2012). Novel vesicular system: an overview. J App Pharm Sci 2:193-202.
7. Jain S, Saraf S. (2009). Influence of processing variables and in vitro characterization of glipizide loaded biodegradable nanoparticles. Diabetes Metabolic Syndrome: Clin Res Rev 3:113-17.
8. Kumar K, Radhika P, Sivakumar T. (2010). Ethosomes - a priority in transdermal drug delivery. Int J Adv Pharm Sci 1:111-21.
9. Kundlik G, Ranju P, Hitesh G. (2010). Ethosomes: a novel vesicular carrier for enhanced dermal delivery of Ciclopirox olamine. Der Pharmacia Lett 2:360-7.
10. Misra AN, Sachin N. (2009). Ethosome - a novel delivery system of antifungal drugs in treatment of topical fungal diseases. Ind J Exp Bio 47:368-75.
11. Sarath Chandran C, Arun S. (2011). Development and evaluation of ethosomes for transdermal delivery of fluconazole. J Chem Bio Phy Sci B2:254-60.
12. Sheo D, Ramchand D. (2011). Enhancement of transdermal permeation of indinavir sulfate via ethosome vesicles. Afr J Pharm Sci 2:33-47.
13. Singh A, Rathore P, Shukla M, Nayak S. (2010). Comparative studies on skin permeation of miconazole using different novel carriers. Int J Pharm Sci Res 1:61-6.
14. Tiwari RK, Chauhan NS, Yogesh HS. (2010). Ethosomes - a potential carries for transdermal drug delivery. Int J Drug Dev Res 2:448-52.
15. Touitou E, Dayana N. (2000). Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Rel 65:403-18.
16. Touitoua E, Godina B, Dayana N. (2001). Intracellular delivery mediated by an ethosomal carrier. Biomaterials 2:3053-9.
17. Verma P. (2011). Transdermal penetration efficacy of ethosomal systems with and without penetration enhancer: a comparative study. Int J Pharm Sci Res 2:2472-4.
18. Verma P, Ram A. (2011). Effect of different penetration enhancers on skin permeation of drug using ethosomal carrier systems. J Curr Pharm Res 5:42-4.